- Home
- BMY vs IBN Comparison
BMY vs IBN Comparison
Compare BMY & IBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- IBN
- Stock Information
- Founded
- BMY 1887
- IBN 1955
- Country
- BMY United States
- IBN India
- Employees
- BMY N/A
- IBN N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- IBN Commercial Banks
- Sector
- BMY Health Care
- IBN Finance
- Exchange
- BMY Nasdaq
- IBN Nasdaq
- Market Cap
- BMY 99.7B
- IBN 119.5B
- IPO Year
- BMY N/A
- IBN 1999
- Fundamental
- Price
- BMY $45.96
- IBN $32.86
- Analyst Decision
- BMY Hold
- IBN
- Analyst Count
- BMY 15
- IBN 0
- Target Price
- BMY $57.64
- IBN N/A
- AVG Volume (30 Days)
- BMY 13.6M
- IBN 4.3M
- Earning Date
- BMY 07-31-2025
- IBN 08-12-2025
- Dividend Yield
- BMY 5.40%
- IBN 0.61%
- EPS Growth
- BMY N/A
- IBN 16.03
- EPS
- BMY 2.49
- IBN 0.86
- Revenue
- BMY $47,704,000,000.00
- IBN $23,959,029,968.00
- Revenue This Year
- BMY N/A
- IBN N/A
- Revenue Next Year
- BMY N/A
- IBN $15.23
- P/E Ratio
- BMY $18.48
- IBN $18.99
- Revenue Growth
- BMY 2.57
- IBN 21.82
- 52 Week Low
- BMY $42.96
- IBN $27.42
- 52 Week High
- BMY $63.33
- IBN $34.57
- Technical
- Relative Strength Index (RSI)
- BMY 47.22
- IBN 40.24
- Support Level
- BMY $44.74
- IBN $32.76
- Resistance Level
- BMY $47.26
- IBN $33.10
- Average True Range (ATR)
- BMY 1.22
- IBN 0.29
- MACD
- BMY -0.12
- IBN -0.12
- Stochastic Oscillator
- BMY 47.47
- IBN 9.13
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About IBN ICICI Bank Limited
ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.